Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

Autor: Aigbogun MS, Liu S, Kamat SA, Sapin C, Duhig AM, Citrome L

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 443-456 (2018)

Myrlene S Aigbogun,1 Sizhu Liu,2 Siddhesh A Kamat,1 Christophe Sapin,3 Amy M Duhig,2 Leslie Citrome4 1Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization, Inc, Princeton, NJ, USA; 2Global Health Economics a

Externí odkaz: https://doaj.org/article/d7e97eda1ddf448eab4b5b3d3057fe58

Impact of agitation in long-term care residents with dementia in the United States.

Autor: Fillit H; Geriatric Medicine, Palliative Care and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Aigbogun MS; Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ, USA., Gagnon-Sanschagrin P; Analysis Group, Inc., Montreal, QC, Canada., Cloutier M; Analysis Group, Inc., Montreal, QC, Canada., Davidson M; Analysis Group, Inc., Montreal, QC, Canada., Serra E; Analysis Group, Inc., Montreal, QC, Canada., Guérin A; Analysis Group, Inc., Montreal, QC, Canada., Baker RA; Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ, USA., Houle CR; Health Economics and Outcomes Research, Lundbeck Pharmaceuticals, Deerfield, IL, USA., Grossberg G; Geriatric Psychiatry, Saint Louis University School of Medicine, Saint Louis, MO, USA.

Publikováno v: International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2021 Dec; Vol. 36 (12), pp. 1959-1969. Date of Electronic Publication: 2021 Aug 27.

Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance.

Autor: Dasgupta, Indranil^1,2 (AUTHOR) indranil.dasgupta@uhb.nhs.uk, Bagnis, Corinne Isnard³ (AUTHOR), Floris, Matteo⁴ (AUTHOR), Furuland, Hans⁵ (AUTHOR), Zurro, Daniel Gallego⁶ (AUTHOR), Gesualdo, Loreto⁷ (AUTHOR), Heirman, Nathalie⁸ (AUTHOR), Minutolo, Roberto⁹ (AUTHOR), Pani, Antonello^4,10 (AUTHOR), Portolés, José^11,12 (AUTHOR), Rosenberger, Christian¹³ (AUTHOR), Alvarez, José Emilio Sánchez¹⁴ (AUTHOR), Torres, Pablo Ureña^15,16 (AUTHOR), Vanholder, Raymond C^17,18 (AUTHOR), Wanner, Christoph¹⁹ (AUTHOR), Alliance, European Anaemia of aCKD (AUTHOR)

Publikováno v: Clinical Kidney Journal. Aug2024, Vol. 17 Issue 8, p1-10. 10p.

The societal economic burden of autosomal dominant polycystic kidney disease in the United States.

Autor: Cloutier M; Analysis Group, Inc., Montréal, QC, Canada., Manceur AM; Analysis Group, Inc., Montréal, QC, Canada., Guerin A; Analysis Group, Inc., Montréal, QC, Canada., Aigbogun MS; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA., Oberdhan D; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA., Gauthier-Loiselle M; Analysis Group, Inc., Montréal, QC, Canada. Marjolaine.Gauthier-Loiselle@analysisgroup.com.

Publikováno v: BMC health services research [BMC Health Serv Res] 2020 Feb 18; Vol. 20 (1), pp. 126. Date of Electronic Publication: 2020 Feb 18.

Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study.

Autor: Nakamura Y; Faculty of Medicine/Graduate School of Medicine, Kagawa University, Kita-gun, Kagawa, Japan., Adachi J; Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd, Minato-ku, Tokyo, Japan., Hirota N; Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd, Minato-ku, Tokyo, Japan., Iba K; Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd, Chuo-ku, Osaka, Japan., Shimizu K; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd, Minato-ku, Tokyo, Japan., Nakai M; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd, Chuo-ku, Osaka, Japan., Takahashi K; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd, Minato-ku, Tokyo, Japan., Mori N; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd, Minato-ku, Tokyo, Japan.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Oct 06. Date of Electronic Publication: 2024 Oct 06.